Grant Number:	1R01CA157458-01A1 Interpret this number
Primary Investigator:	Carlin, Bradley
Organization:	University Of Minnesota
Project Title:	Statistical Methods and Software for More Efficient, Ethical, and Affordable Clin
Fiscal Year:	2012

DESCRIPTION (provided by applicant): Clinical trials are becoming increasingly expensive, and patients are more and more reluctant to enroll and to persist with the protocol, further increasing costs. We propose to develop Bayesian statistical methods and software for more efficient, ethical, and affordable clinical trials. These methods incorporate all sources of knowledge (structural constraints, expert opinion, and both historical and experimental data), thus reducing sample size and typically leading to increases in statistical power and reductions in cost and ethical hazard, since fewer patients need be exposed to the inferior treatment. The methods are also better able to adapt to unanticipated changes that inevitably arise as the trial progresses. In Aim 1 we will develop novel methods to exploit available historical data. In Aim 2 we look at the more general problem of combining inference across related subpopulations, when the subpopulations are not exchangeable. Here our approach is based on random clustering of subpopulations. Finally, Aim 3 is concerned with the development of user-friendly computer code that can be publicly distributed. The end result will be clinical trials that come to conclusions more quickly with fewer patients randomized to inferior treatments. Our methods and software should have immediate impact on practice not only for early phase studies, but for large confirmatory trials as well. In the longer term, improvements in trial compliance and accrual should also obtain. PUBLIC HEALTH RELEVANCE: The relevance of this work to public health lies in its ability to randomize fewer patients to control groups in clinical trials, since reliable historical information on such groups will be brought to bear. Patients are thus treated more ethically, and trial conclusions are obtained more quickly. The work has a potentially large impact on small studies of interventions in cancer, alcohol, and many other areas where sample sizes are small yet other sources of information exist that can accelerate the process while maintaining scientific integrity.




Pharmacokinetic/pharmacodynamic data extrapolation models for improved pediatric efficacy and toxicity estimation, with application to secondary hyperparathyroidism.
Authors: Basu C. , Ma X. , Mo M. , Xia H.A. , Brundage R. , Al-Kofahi M. , Carlin B.P. .
Source: Pharmaceutical Statistics, 2020-07-09 00:00:00.0; , .
EPub date: 2020-07-09 00:00:00.0.
PMID: 32648333
Related Citations

Borrowing from Historical Control Data in Cancer Drug Development: A Cautionary Tale and Practical Guidelines.
Authors: Lewis C.J. , Sarkar S. , Zhu J. , Carlin B.P. .
Source: Statistics In Biopharmaceutical Research, 2019; 11(1), p. 67-78.
EPub date: 2019-04-22 00:00:00.0.
PMID: 31435458
Related Citations

Multiplicity-adjusted semiparametric benefiting subgroup identification in clinical trials.
Authors: Schnell P.M. , Müller P. , Tang Q. , Carlin B.P. .
Source: Clinical Trials (london, England), 2018 02; 15(1), p. 75-86.
EPub date: 2017-10-16 00:00:00.0.
PMID: 29035083
Related Citations

Bayesian nonparametric statistics: A new toolkit for discovery in cancer research.
Authors: Thall P.F. , Mueller P. , Xu Y. , Guindani M. .
Source: Pharmaceutical Statistics, 2017-07-04 00:00:00.0; , .
EPub date: 2017-07-04 00:00:00.0.
PMID: 28677272
Related Citations

A Bayesian credible subgroups approach to identifying patient subgroups with positive treatment effects.
Authors: Schnell P.M. , Tang Q. , Offen W.W. , Carlin B.P. .
Source: Biometrics, 2016 Dec; 72(4), p. 1026-1036.
PMID: 27159131
Related Citations

A practical Bayesian stepped wedge design for community-based cluster-randomized clinical trials: The British Columbia Telehealth Trial.
Authors: Cunanan K.M. , Carlin B.P. , Peterson K.A. .
Source: Clinical Trials (london, England), 2016 Dec; 13(6), p. 641-650.
PMID: 27430710
Related Citations

Detecting And Accounting For Violations Of The Constancy Assumption In Non-inferiority Clinical Trials
Authors: Koopmeiners J.S. , Hobbs B.P. .
Source: Statistical Methods In Medical Research, 2016-09-01 00:00:00.0; , .
PMID: 27587591
Related Citations

Combining Non-randomized and Randomized Data in Clinical Trials Using Commensurate Priors.
Authors: Zhao H. , Hobbs B.P. , Ma H. , Jiang Q. , Carlin B.P. .
Source: Health Services & Outcomes Research Methodology, 2016 Sep; 16(3), p. 154-171.
EPub date: 2016-08-06 00:00:00.0.
PMID: 28458614
Related Citations

Flexible Bayesian survival modeling with semiparametric time-dependent and shape-restricted covariate effects.
Authors: Murray T.A. , Hobbs B.P. , Sargent D.J. , Carlin B.P. .
Source: Bayesian Analysis, 2016 Jun; 11(2), p. 381-402.
PMID: 27042243
Related Citations

Subgroup-Based Adaptive (SUBA) Designs for Multi-Arm Biomarker Trials.
Authors: Xu Y. , Trippa L. , Müller P. , Ji Y. .
Source: Statistics In Biosciences, 2016 Jun; 8(1), p. 159-180.
PMID: 27617041
Related Citations

A decision-theoretic phase I-II design for ordinal outcomes in two cycles.
Authors: Lee J. , Thall P.F. , Ji Y. , Müller P. .
Source: Biostatistics (oxford, England), 2016 Apr; 17(2), p. 304-19.
PMID: 26553915
Related Citations

A Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons.
Authors: Hong H. , Chu H. , Zhang J. , Carlin B.P. .
Source: Research Synthesis Methods, 2016 Mar; 7(1), p. 6-22.
PMID: 26536149
Related Citations

A Hierarchical Bayesian Approach For Combining Pharmacokinetic/pharmacodynamic Modeling And Phase Iia Trial Design In Orphan Drugs: Treating Adrenoleukodystrophy With Lorenzo's Oil
Authors: Basu C. , Ahmed M.A. , Kartha R.V. , Brundage R.C. , Raymond G.V. , Cloyd J.C. , Carlin B.P. .
Source: Journal Of Biopharmaceutical Statistics, 2016; 26(6), p. 1025-1039.
PMID: 27547896
Related Citations

Bayesian Nonparametric Estimation For Dynamic Treatment Regimes With Sequential Transition Times
Authors: Xu Y. , Müller P. , Wahed A.S. , Thall P.F. .
Source: Journal Of The American Statistical Association, 2016; 111(515), p. 921-935.
PMID: 28018015
Related Citations

Predictive classification of correlated targets with application to detection of metastatic cancer using functional CT imaging.
Authors: Wang Y. , Hobbs B.P. , Hu J. , Ng C.S. , Do K.A. .
Source: Biometrics, 2015 Sep; 71(3), p. 792-802.
PMID: 25851056
Related Citations

COMBINING NONEXCHANGEABLE FUNCTIONAL OR SURVIVAL DATA SOURCES IN ONCOLOGY USING GENERALIZED MIXTURE COMMENSURATE PRIORS.
Authors: Murray T.A. , Hobbs B.P. , Carlin B.P. .
Source: The Annals Of Applied Statistics, 2015 Sep; 9(3), p. 1549-1570.
PMID: 26557211
Related Citations

Detecting outlying trials in network meta-analysis.
Authors: Zhang J. , Fu H. , Carlin B.P. .
Source: Statistics In Medicine, 2015-08-30 00:00:00.0; 34(19), p. 2695-707.
EPub date: 2015-08-30 00:00:00.0.
PMID: 25851533
Related Citations

Bayesian hierarchical models for network meta-analysis incorporating nonignorable missingness.
Authors: Zhang J. , Chu H. , Hong H. , Virnig B.A. , Carlin B.P. .
Source: Statistical Methods In Medical Research, 2015-07-28 00:00:00.0; , .
EPub date: 2015-07-28 00:00:00.0.
PMID: 26220535
Related Citations

Bayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and Toxicity.
Authors: Lee J. , Thall P.F. , Ji Y. , Müller P. .
Source: Journal Of The American Statistical Association, 2015-06-01 00:00:00.0; 110(510), p. 711-722.
PMID: 26366026
Related Citations

On nonparametric hazard estimation.
Authors: Hobbs B.P. .
Source: Journal Of Biometrics & Biostatistics, 2015; 6, .
PMID: 26509102
Related Citations

Network meta-analysis of randomized clinical trials: reporting the proper summaries.
Authors: Zhang J. , Carlin B.P. , Neaton J.D. , Soon G.G. , Nie L. , Kane R. , Virnig B.A. , Chu H. .
Source: Clinical Trials (london, England), 2014 Apr; 11(2), p. 246-62.
PMID: 24096635
Related Citations

Bayesian inference for longitudinal data with non-parametric treatment effects.
Authors: Müller P. , Quintana F.A. , Rosner G.L. , Maitland M.L. .
Source: Biostatistics (oxford, England), 2014 Apr; 15(2), p. 341-52.
PMID: 24285773
Related Citations

Semiparametric Bayesian commensurate survival model for post-market medical device surveillance with non-exchangeable historical data.
Authors: Murray T.A. , Hobbs B.P. , Lystig T.C. , Carlin B.P. .
Source: Biometrics, 2014 Mar; 70(1), p. 185-91.
PMID: 24308779
Related Citations

Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis.
Authors: Ohlssen D. , Price K.L. , Xia H.A. , Hong H. , Kerman J. , Fu H. , Quartey G. , Heilmann C.R. , Ma H. , Carlin B.P. .
Source: Pharmaceutical Statistics, 2014 Jan-Feb; 13(1), p. 55-70.
PMID: 24038897
Related Citations

A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials.
Authors: Zhong W. , Koopmeiners J.S. , Carlin B.P. .
Source: Contemporary Clinical Trials, 2013 Nov; 36(2), p. 587-96.
PMID: 23583925
Related Citations

Bayesian adaptive design for device surveillance.
Authors: Murray T.A. , Carlin B.P. , Lystig T.C. .
Source: Clinical Trials (london, England), 2013 Feb; 10(1), p. 5-18.
PMID: 23188891
Related Citations

Discussion of 'small-sample behavior of novel phase I cancer trial designs' by Assaf P Oron and Peter D Hoff.
Authors: Carlin B.P. , Zhong W. , Koopmeiners J.S. .
Source: Clinical Trials (london, England), 2013 Feb; 10(1), p. 81-5; discussion 88-92.
PMID: 23345305
Related Citations

Adaptive adjustment of the randomization ratio using historical control data.
Authors: Hobbs B.P. , Carlin B.P. , Sargent D.J. .
Source: Clinical Trials (london, England), 2013; 10(3), p. 430-40.
PMID: 23690095
Related Citations

Bayesian Nonparametric Inference - Why and How.
Authors: Müller P. , Mitra R. .
Source: Bayesian Analysis, 2013; 8(2), .
PMID: 24368932
Related Citations

Commensurate Priors for Incorporating Historical Information in Clinical Trials Using General and Generalized Linear Models.
Authors: Hobbs B.P. , Sargent D.J. , Carlin B.P. .
Source: Bayesian Analysis, 2012-08-28 00:00:00.0; 7(3), p. 639-674.
PMID: 24795786
Related Citations